{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T13:30:13Z","timestamp":1780320613447,"version":"3.54.1"},"reference-count":198,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T00:00:00Z","timestamp":1763078400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["C43C22001380007"],"award-info":[{"award-number":["C43C22001380007"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.nbd.2025.107194","type":"journal-article","created":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T09:34:16Z","timestamp":1763631256000},"page":"107194","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["The role of dopaminergic signalling from physiology to neuroprotection in acute and chronic disorders"],"prefix":"10.1016","volume":"217","author":[{"given":"Martina","family":"Di Nunzio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Lidia","family":"Mignogna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Bacigaluppi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Panina-Bordignon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Ragonese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Muzio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Summa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianvito","family":"Martino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2025.107194_bb0005","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2024.1347987","article-title":"The role of neuroinflammation in neurodegenerative diseases: current understanding and future therapeutic targets","volume":"16","author":"Adamu","year":"2024","journal-title":"Front. Aging Neurosci."},{"issue":"5","key":"10.1016\/j.nbd.2025.107194_bb0010","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1161\/01.STR.22.5.674","article-title":"Biphasic striatal dopamine release during transient ischemia and reperfusion in gerbils","volume":"22","author":"Ahn","year":"1991","journal-title":"Stroke"},{"issue":"1","key":"10.1016\/j.nbd.2025.107194_bb0015","doi-asserted-by":"crossref","first-page":"17018","DOI":"10.1038\/nrdp.2017.18","article-title":"Traumatic spinal cord injury","volume":"3","author":"Ahuja","year":"2017","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"1","key":"10.1016\/j.nbd.2025.107194_bb0020","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3390\/biomedicines9010047","article-title":"Quinpirole-mediated regulation of dopamine D2 receptors inhibits glial cell-induced Neuroinflammation in cortex and striatum after brain injury","volume":"9","author":"Alam","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.nbd.2025.107194_bb0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainres.2012.01.046","article-title":"Effects of dexpramipexole on brain mitochondrial conductances and cellular bioenergetic efficiency","volume":"1446","author":"Alavian","year":"2012","journal-title":"Brain Res."},{"issue":"8","key":"10.1016\/j.nbd.2025.107194_bb0030","doi-asserted-by":"crossref","DOI":"10.1242\/dmm.033860","article-title":"Pramipexole prevents ischemic cell death via mitochondrial pathways in ischemic stroke","volume":"12","author":"Andrabi","year":"2019","journal-title":"Dis. Model. Mech."},{"issue":"2","key":"10.1016\/j.nbd.2025.107194_bb0035","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/jcbfm.2012.167","article-title":"Ischemic-LTP in striatal spiny neurons of both direct and indirect pathway requires the activation of D1-like receptors and NO\/soluble guanylate cyclase\/cGMP transmission","volume":"33","author":"Arcangeli","year":"2013","journal-title":"J. Cereb. Blood Flow Metab."},{"issue":"2","key":"10.1016\/j.nbd.2025.107194_bb0040","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1006\/exnr.2002.8033","article-title":"Dopamine receptor agonists mediate neuroprotection in malonate-induced striatal lesion in the rat","volume":"178","author":"Armentero","year":"2002","journal-title":"Exp. Neurol."},{"issue":"2","key":"10.1016\/j.nbd.2025.107194_bb0045","doi-asserted-by":"crossref","DOI":"10.4172\/2471-271X.1000120","article-title":"Dopamine: receptors, functions, synthesis, pathways, locations and mental disorders: review of literatures","volume":"2","author":"Ayano","year":"2016","journal-title":"J. Mental Disord. Treat."},{"issue":"Pt 8","key":"10.1016\/j.nbd.2025.107194_bb0050","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1093\/brain\/awp174","article-title":"Delayed post-ischaemic neuroprotection following systemic neural stem cell transplantation involves multiple mechanisms","volume":"132","author":"Bacigaluppi","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2025.107194_bb0055","first-page":"119","article-title":"Targeting dopamine in acute traumatic brain injury","volume":"2","author":"Bales","year":"2010","journal-title":"Open Drug Discovery J."},{"issue":"2","key":"10.1016\/j.nbd.2025.107194_bb0060","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/s12276-021-00563-5","article-title":"The dopamine D1\u2013D2DR complex in the rat spinal cord promotes neuropathic pain by increasing neuronal excitability after chronic constriction injury","volume":"53","author":"Bao","year":"2021","journal-title":"Exp. Mol. Med."},{"issue":"1","key":"10.1016\/j.nbd.2025.107194_bb0065","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1124\/pr.110.002642","article-title":"The physiology, signaling, and pharmacology of dopamine receptors","volume":"63","author":"Beaulieu","year":"2011","journal-title":"Pharmacol. Rev."},{"issue":"3","key":"10.1016\/j.nbd.2025.107194_bb0070","doi-asserted-by":"crossref","first-page":"502","DOI":"10.3390\/neurolint16030037","article-title":"Oxidative stress and neurodegeneration: insights and therapeutic strategies for Parkinson\u2019s disease","volume":"16","author":"Bej","year":"2024","journal-title":"Neurol. Int."},{"issue":"6","key":"10.1016\/j.nbd.2025.107194_bb0075","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1210\/edrv.22.6.0451","article-title":"Dopamine as a prolactin (PRL) inhibitor","volume":"22","author":"Ben-Jonathan","year":"2001","journal-title":"Endocr. Rev."},{"issue":"14","key":"10.1016\/j.nbd.2025.107194_bb0080","doi-asserted-by":"crossref","first-page":"832","DOI":"10.12968\/bjon.1998.7.14.5636","article-title":"Role of dopamine in schizophrenia and Parkinson\u2019s disease","volume":"7","author":"Birtwistle","year":"1998","journal-title":"Br. J. Nurs."},{"issue":"5","key":"10.1016\/j.nbd.2025.107194_bb0085","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.tins.2007.03.006","article-title":"Dopamine neuron systems in the brain: an update","volume":"30","author":"Bj\u00f6rklund","year":"2007","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.nbd.2025.107194_bb0090","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2021.682597","article-title":"Neurotrophic factors in Parkinson\u2019s disease: clinical trials, open challenges and nanoparticle-mediated delivery to the brain","volume":"15","author":"Bondarenko","year":"2021","journal-title":"Front. Cell. Neurosci."},{"issue":"12","key":"10.1016\/j.nbd.2025.107194_bb0095","doi-asserted-by":"crossref","first-page":"5671","DOI":"10.3390\/ijms26125671","article-title":"Perspectives in amyotrophic lateral sclerosis: biomarkers, omics, and gene therapy informing disease and treatment","volume":"26","author":"Bono","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.nbd.2025.107194_bb0100","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1136\/jnnp.65.2.263","article-title":"Dopaminergic deficit in amyotrophic lateral sclerosis assessed with [I-123] IPT single photon emission computed tomography","volume":"65","author":"Borasio","year":"1998","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"1","key":"10.1016\/j.nbd.2025.107194_bb0105","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1152\/ajpgi.00076.2019","article-title":"Altered gastric tone and motility response to brain-stem dopamine in a rat model of parkinsonism","volume":"317","author":"Bove","year":"2019","journal-title":"Am. J. Physiol.-Gastrointestinal Liver Physiol."},{"issue":"22","key":"10.1016\/j.nbd.2025.107194_bb0110","doi-asserted-by":"crossref","first-page":"8643","DOI":"10.1523\/JNEUROSCI.20-22-08643.2000","article-title":"Neuroprotective role of dopamine against hippocampal cell death","volume":"20","author":"Bozzi","year":"2000","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.nbd.2025.107194_bb0115","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s100720070114","article-title":"Bromocriptine and speech therapy in non-fluent chronic aphasia after stroke","volume":"21","author":"Bragoni","year":"2000","journal-title":"Neurol. Sci."},{"issue":"1","key":"10.1016\/j.nbd.2025.107194_bb0120","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/ana.23937","article-title":"Stages of pTDP-43 pathology in amyotrophic lateral sclerosis","volume":"74","author":"Brettschneider","year":"2013","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2025.107194_bb0125","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2020.00363","article-title":"Cortical circuit dysfunction as a potential driver of amyotrophic lateral sclerosis","volume":"14","author":"Brunet","year":"2020","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.nbd.2025.107194_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2024.106506","article-title":"Dopamine-iron homeostasis interaction rescues mitochondrial fitness in Parkinson\u2019s disease","volume":"196","author":"Buoso","year":"2024","journal-title":"Neurobiol. Dis."},{"issue":"4","key":"10.1016\/j.nbd.2025.107194_bb0135","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1111\/j.1468-1331.2006.01235.x","article-title":"Dopamine transporter immunoreactivity in peripheral blood mononuclear cells in amyotrophic lateral sclerosis","volume":"13","author":"Buttarelli","year":"2006","journal-title":"Eur. J. Neurol."},{"issue":"8","key":"10.1016\/j.nbd.2025.107194_bb0140","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1038\/nn.3743","article-title":"Direct and indirect pathways of basal ganglia: a critical reappraisal","volume":"17","author":"Calabresi","year":"2014","journal-title":"Nat. Neurosci."},{"issue":"4","key":"10.1016\/j.nbd.2025.107194_bb0145","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.3390\/ijms25042224","article-title":"Brain plasticity in patients with spinal cord injuries: a systematic review","volume":"25","author":"Calderone","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.nbd.2025.107194_bb0150","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2017.00666","article-title":"The dopamine D5 receptor is involved in working memory","volume":"8","author":"Carr","year":"2017","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.nbd.2025.107194_bb0155","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1038\/s41598-020-59011-5","article-title":"The dopamine D5 receptor contributes to activation of cholinergic interneurons during L-DOPA induced dyskinesia","volume":"10","author":"Castello","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.nbd.2025.107194_bb0160","series-title":"The Role of Dopamine in Huntington's Disease","first-page":"235","author":"Cepeda","year":"2014"},{"issue":"1","key":"10.1016\/j.nbd.2025.107194_bb0165","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1124\/pharmrev.122.000618","article-title":"Dopamine, immunity, and disease","volume":"75","author":"Channer","year":"2023","journal-title":"Pharmacol. Rev."},{"issue":"12","key":"10.1016\/j.nbd.2025.107194_bb0170","first-page":"911","article-title":"Dexpramipexole, the R(+) enantiomer of pramipexole, for the potential treatment of amyotrophic lateral sclerosis","volume":"13","author":"Cheah","year":"2010","journal-title":"IDrugs"},{"issue":"7","key":"10.1016\/j.nbd.2025.107194_bb0175","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0002804","article-title":"Dopamine inhibits mitochondrial motility in hippocampal neurons","volume":"3","author":"Chen","year":"2008","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.nbd.2025.107194_bb0180","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1177\/0963689717714105","article-title":"Impact of traumatic brain injury on dopaminergic transmission","volume":"26","author":"Chen","year":"2017","journal-title":"Cell Transplant."},{"issue":"6","key":"10.1016\/j.nbd.2025.107194_bb0185","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.amjmed.2004.03.032","article-title":"Clinical differentiation of parkinsonian syndromes: prognostic and therapeutic relevance","volume":"117","author":"Christine","year":"2004","journal-title":"Am. J. Med."},{"issue":"3","key":"10.1016\/j.nbd.2025.107194_bb0190","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.ncl.2007.04.003","article-title":"Subcortical ischemic vascular dementia","volume":"25","author":"Chui","year":"2007","journal-title":"Neurol. Clin."},{"key":"10.1016\/j.nbd.2025.107194_bb0195","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.brainresbull.2014.06.003","article-title":"Dopaminergic modulation of neuropathic pain: analgesia in rats by a D2-type receptor agonist","volume":"106","author":"Cobacho","year":"2014","journal-title":"Brain Res. Bull."},{"issue":"10440","key":"10.1016\/j.nbd.2025.107194_bb0200","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1016\/S0140-6736(24)00476-8","volume":"403","author":"Collaborators","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.nbd.2025.107194_bb0285","first-page":"359","article-title":"Amyotrophic lateral sclerosis and the clinical potential of dexpramipexole","author":"Corcia","year":"2012","journal-title":"Ther. Clin. Risk Manag."},{"issue":"3","key":"10.1016\/j.nbd.2025.107194_bb0205","doi-asserted-by":"crossref","DOI":"10.1523\/ENEURO.0081-20.2020","article-title":"Dopamine D2-like receptors modulate intrinsic properties and synaptic transmission of Parvalbumin interneurons in the mouse primary motor cortex","volume":"7","author":"Cousineau","year":"2020","journal-title":"eneuro"},{"issue":"9","key":"10.1016\/j.nbd.2025.107194_bb0210","doi-asserted-by":"crossref","first-page":"3034","DOI":"10.1161\/STROKEAHA.109.552075","article-title":"Randomized, placebo-controlled, double-blind study of ropinirole in chronic stroke","volume":"40","author":"Cramer","year":"2009","journal-title":"Stroke"},{"issue":"12","key":"10.1016\/j.nbd.2025.107194_bb0215","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1038\/nm.2579","article-title":"The effects of dexpramipexole (KNS-760704) in individuals with amyotrophic lateral sclerosis","volume":"17","author":"Cudkowicz","year":"2011","journal-title":"Nat. Med."},{"issue":"11","key":"10.1016\/j.nbd.2025.107194_bb0220","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/S1474-4422(13)70221-7","article-title":"Dexpramipexole versus placebo for patients with amyotrophic lateral sclerosis (EMPOWER): a randomised, double-blind, phase 3 trial","volume":"12","author":"Cudkowicz","year":"2013","journal-title":"Lancet Neurol."},{"issue":"1","key":"10.1016\/j.nbd.2025.107194_bb0225","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0169-328X(96)00235-5","article-title":"Distribution of D4 dopamine receptor in rat brain with sequence-specific antibodies","volume":"45","author":"Defagot","year":"1997","journal-title":"Mol. Brain Res."},{"issue":"31","key":"10.1016\/j.nbd.2025.107194_bb0230","doi-asserted-by":"crossref","first-page":"23446","DOI":"10.1074\/jbc.M000157200","article-title":"Dopamine D5 receptor agonist high affinity and constitutive activity profile conferred by carboxyl-terminal tail sequence","volume":"275","author":"Demchyshyn","year":"2000","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.nbd.2025.107194_bb0235","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S1474-4422(12)70262-4","article-title":"Incidence of traumatic brain injury in New Zealand: a population-based study","volume":"12","author":"Feigin","year":"2013","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.nbd.2025.107194_bb0240","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.663102","article-title":"Immunomodulatory effects of dopamine in inflammatory diseases","volume":"12","author":"Feng","year":"2021","journal-title":"Front. Immunol."},{"issue":"2_suppl","key":"10.1016\/j.nbd.2025.107194_bb0245","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1177\/0269216307087148","article-title":"Prolactin and dopamine: what is the connection? A review article","volume":"22","author":"Fitzgerald","year":"2008","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.nbd.2025.107194_bb0250","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2013.00062","article-title":"Prefrontal dopamine and behavioral flexibility: shifting from an \u201cinverted-U\u201d toward a family of functions","volume":"7","author":"Floresco","year":"2013","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.nbd.2025.107194_bb0255","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jns.2017.03.013","article-title":"18 F-fallypride PET-CT of dopamine D2\/D3 receptors in patients with sporadic amyotrophic lateral sclerosis","volume":"377","author":"Fu","year":"2017","journal-title":"J. Neurol. Sci."},{"issue":"10","key":"10.1016\/j.nbd.2025.107194_bb0260","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1038\/s41591-018-0140-5","article-title":"Modeling sporadic ALS in iPSC-derived motor neurons identifies a potential therapeutic agent","volume":"24","author":"Fujimori","year":"2018","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.nbd.2025.107194_bb0265","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s12028-020-00977-5","article-title":"Amantadine and Modafinil as Neurostimulants during post-stroke care: a systematic review","volume":"33","author":"Gagnon","year":"2020","journal-title":"Neurocrit. Care."},{"key":"10.1016\/j.nbd.2025.107194_bb0270","first-page":"14","article-title":"Segregation of D1 and D2 dopamine receptors in the striatal direct and indirect pathways: an historical perspective","author":"Gerfen","year":"2023","journal-title":"Front. Synaptic Neurosci."},{"issue":"9","key":"10.1016\/j.nbd.2025.107194_bb0275","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1056\/NEJMoa1102609","article-title":"Placebo-controlled trial of amantadine for severe traumatic brain injury","volume":"366","author":"Giacino","year":"2012","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.nbd.2025.107194_bb0280","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/0304-3940(87)90463-0","article-title":"Substantia nigra lesion protects against ischemic damage in the striatum","volume":"80","author":"Globus","year":"1987","journal-title":"Neurosci. Lett."},{"issue":"3","key":"10.1016\/j.nbd.2025.107194_bb0290","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.biopsych.2009.08.026","article-title":"Functional and dysfunctional synaptic plasticity in prefrontal cortex: roles in psychiatric disorders","volume":"67","author":"Goto","year":"2010","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.nbd.2025.107194_bb0295","first-page":"10","article-title":"The intersection of central dopamine system and stroke: potential avenues aiming at enhancement of motor recovery","author":"Gower","year":"2018","journal-title":"Front. Synaptic Neurosci."},{"issue":"16","key":"10.1016\/j.nbd.2025.107194_bb0300","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1089\/neu.2014.3803","article-title":"Amantadine effect on perceptions of irritability after traumatic brain injury: results of the amantadine irritability multisite study","volume":"32","author":"Hammond","year":"2015","journal-title":"J. Neurotrauma"},{"issue":"2","key":"10.1016\/j.nbd.2025.107194_bb0305","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1007\/s11906-012-0253-z","article-title":"Dopamine, the kidney, and hypertension","volume":"14","author":"Harris","year":"2012","journal-title":"Curr. Hypertens. Rep."},{"issue":"1","key":"10.1016\/j.nbd.2025.107194_bb0310","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s13293-020-00285-9","article-title":"Sex difference in dopamine D1-D2 receptor complex expression and signaling affects depression- and anxiety-like behaviors","volume":"11","author":"Hasbi","year":"2020","journal-title":"Biol. Sex Differ."},{"key":"10.1016\/j.nbd.2025.107194_bb0315","series-title":"Classification of Traumatic Brain Injury","first-page":"15","author":"Hawryluk","year":"2015"},{"issue":"4","key":"10.1016\/j.nbd.2025.107194_bb0320","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s00702-019-01989-y","article-title":"Classical dopamine agonists","volume":"126","author":"Horowski","year":"2019","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.nbd.2025.107194_bb0325","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.expneurol.2015.12.001","article-title":"Dopamine is produced in the rat spinal cord and regulates micturition reflex after spinal cord injury","volume":"285","author":"Hou","year":"2016","journal-title":"Exp. Neurol."},{"issue":"1","key":"10.1016\/j.nbd.2025.107194_bb0330","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/s41392-023-01477-6","article-title":"Spinal cord injury: molecular mechanisms and therapeutic interventions","volume":"8","author":"Hu","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"issue":"10","key":"10.1016\/j.nbd.2025.107194_bb0335","doi-asserted-by":"crossref","first-page":"109224","DOI":"10.1016\/j.celrep.2021.109224","article-title":"Human amyotrophic lateral sclerosis excitability phenotype screen: target discovery and validation","volume":"35","author":"Huang","year":"2021","journal-title":"Cell Rep."},{"issue":"22","key":"10.1016\/j.nbd.2025.107194_bb0340","doi-asserted-by":"crossref","DOI":"10.3390\/ijms242216084","article-title":"Sex-specific and traumatic brain injury effects on dopamine receptor expression in the Hippocampus","volume":"24","author":"Iannucci","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.nbd.2025.107194_bb0345","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1080\/01616412.1997.11740831","article-title":"Bromocriptine prevents neuron damage following inhibition of superoxide dismutase in cultured ventral spinal cord neurons","volume":"19","author":"Iwasaki","year":"1997","journal-title":"Neurol. Res."},{"issue":"5","key":"10.1016\/j.nbd.2025.107194_bb0350","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1007\/s11064-020-03002-5","article-title":"Monoaminergic and Kynurenergic characterization of frontotemporal dementia and amyotrophic lateral sclerosis in cerebrospinal fluid and serum","volume":"45","author":"Janssens","year":"2020","journal-title":"Neurochem. Res."},{"issue":"6","key":"10.1016\/j.nbd.2025.107194_bb0355","doi-asserted-by":"crossref","first-page":"E330","DOI":"10.1097\/BRS.0000000000001287","article-title":"Dopamine D1 receptor agonist A-68930 inhibits NLRP3 Inflammasome activation, controls inflammation, and alleviates histopathology in a rat model of spinal cord injury","volume":"41","author":"Jiang","year":"2016","journal-title":"SPINE"},{"key":"10.1016\/j.nbd.2025.107194_bb0360","doi-asserted-by":"crossref","first-page":"136935","DOI":"10.1016\/j.neulet.2022.136935","article-title":"Dopamine inhibits pyroptosis and attenuates secondary damage after spinal cord injury in female mice","volume":"792","author":"Jiang","year":"2023","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.nbd.2025.107194_bb0365","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2021.806618","article-title":"The signaling and pharmacology of the dopamine D1 receptor","volume":"15","author":"Jones-Tabah","year":"2022","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.nbd.2025.107194_bb0370","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.nbd.2013.04.012","article-title":"NAP (davunetide) modifies disease progression in a mouse model of severe neurodegeneration: protection against impairments in axonal transport","volume":"56","author":"Jouroukhin","year":"2013","journal-title":"Neurobiol. Dis."},{"issue":"12","key":"10.1016\/j.nbd.2025.107194_bb0375","doi-asserted-by":"crossref","first-page":"e1278","DOI":"10.1212\/WNL.0000000000200891","article-title":"Longitudinal dopamine D2 receptor changes and cerebrovascular health in aging","volume":"99","author":"Karalija","year":"2022","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.nbd.2025.107194_bb0380","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/j.1365-2990.1993.tb00444.x","article-title":"Diminution of dopaminergic neurons in the substantia nigra of sporadic amyotrophic lateral sclerosis","volume":"19","author":"Kato","year":"1993","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.nbd.2025.107194_bb0385","doi-asserted-by":"crossref","first-page":"118349","DOI":"10.1016\/j.lfs.2020.118349","article-title":"Post-ischemic administration of dopamine D2 receptor agonist reduces cell death by activating mitochondrial pathway following ischemic stroke","volume":"261","author":"Kaushik","year":"2020","journal-title":"Life Sci."},{"key":"10.1016\/j.nbd.2025.107194_bb0390","doi-asserted-by":"crossref","first-page":"103747","DOI":"10.1016\/j.nicl.2025.103747","article-title":"Post-stroke outcome prediction based on lesion-derived features","volume":"45","author":"Khalilian","year":"2025","journal-title":"NeuroImage: Clin."},{"issue":"1","key":"10.1016\/j.nbd.2025.107194_bb0395","doi-asserted-by":"crossref","first-page":"109","DOI":"10.2174\/187152706784111560","article-title":"Dopamine and the diseased brain","volume":"5","author":"Kienast","year":"2006","journal-title":"CNS Neurol. Disord. Drug Targets"},{"issue":"3","key":"10.1016\/j.nbd.2025.107194_bb0400","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1002\/jnr.10426","article-title":"Protective effect of dopamine D2 agonists in cortical neurons via the phosphatidylinositol 3 kinase cascade","volume":"70","author":"Kihara","year":"2002","journal-title":"J. Neurosci. Res."},{"issue":"1","key":"10.1016\/j.nbd.2025.107194_bb0405","doi-asserted-by":"crossref","first-page":"104","DOI":"10.3390\/biom11010104","article-title":"Neuronal dopamine D3 receptors: translational implications for preclinical research and CNS disorders","volume":"11","author":"Kiss","year":"2021","journal-title":"Biomolecules"},{"issue":"1","key":"10.1016\/j.nbd.2025.107194_bb0410","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s10571-018-0632-3","article-title":"Dopamine: functions, signaling, and association with neurological diseases","volume":"39","author":"Klein","year":"2019","journal-title":"Cell. Mol. Neurobiol."},{"issue":"3","key":"10.1016\/j.nbd.2025.107194_bb0415","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/0091-3057(94)90345-X","article-title":"Methylphenidate treatment following ablation-induced hemiplegia in rat: experience during drug action alters effects on recovery of function","volume":"48","author":"Kline","year":"1994","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"3","key":"10.1016\/j.nbd.2025.107194_bb0420","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0304-3940(00)00797-7","article-title":"Chronic methylphenidate treatment enhances water maze performance following traumatic brain injury in rats","volume":"280","author":"Kline","year":"2000","journal-title":"Neurosci. Lett."},{"issue":"12","key":"10.1016\/j.nbd.2025.107194_bb0425","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1089\/neu.2004.21.1712","article-title":"Bromocriptine reduces lipid peroxidation and enhances spatial learning and hippocampal neuron survival in a rodent model of focal brain trauma","volume":"21","author":"Kline","year":"2004","journal-title":"J. Neurotrauma"},{"issue":"4","key":"10.1016\/j.nbd.2025.107194_bb0430","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1002\/ana.410410413","article-title":"Midbrain dopaminergic neuronal degeneration in a transgenic mouse model of familial amyotrophic lateral sclerosis","volume":"41","author":"Kostic","year":"1997","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2025.107194_bb0435","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2018.00187","article-title":"The D2 dopamine receptor interferes with the protective effect of the A2A adenosine receptor on TDP-43 Mislocalization in experimental models of motor neuron degeneration","volume":"12","author":"Lai","year":"2018","journal-title":"Front. Neurosci."},{"issue":"39","key":"10.1016\/j.nbd.2025.107194_bb0440","doi-asserted-by":"crossref","first-page":"13488","DOI":"10.1523\/JNEUROSCI.1638-12.2012","article-title":"The conserved dopaminergic Diencephalospinal tract mediates vertebrate locomotor development in zebrafish larvae","volume":"32","author":"Lambert","year":"2012","journal-title":"J. Neurosci."},{"issue":"5","key":"10.1016\/j.nbd.2025.107194_bb0445","first-page":"2616","article-title":"The potential roles of dopamine in traumatic brain injury: a preclinical and clinical update","volume":"11","author":"Lan","year":"2019","journal-title":"Am. J. Transl. Res."},{"issue":"4","key":"10.1016\/j.nbd.2025.107194_bb0450","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s12640-013-9408-1","article-title":"Intranasal and subcutaneous administration of dopamine D3 receptor agonists functionally restores nigrostriatal dopamine in MPTP-treated mice","volume":"24","author":"Lao","year":"2013","journal-title":"Neurotox. Res."},{"issue":"1","key":"10.1016\/j.nbd.2025.107194_bb0455","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/BF03033298","article-title":"Dopamine and glutamate dysfunctions in schizophrenia: role of the dopamine D3 receptor","volume":"6","author":"Leriche","year":"2004","journal-title":"Neurotox. Res."},{"issue":"1","key":"10.1016\/j.nbd.2025.107194_bb0460","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0304-3940(01)01692-5","article-title":"D3 dopamine receptors in rat spinal cord: implications for sensory and motor function","volume":"303","author":"Levant","year":"2001","journal-title":"Neurosci. Lett."},{"issue":"1","key":"10.1016\/j.nbd.2025.107194_bb0465","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/apha.12476","article-title":"Dopamine and T cells: dopamine receptors and potent effects on T cells, dopamine production in T cells, and abnormalities in the dopaminergic system in T cells in autoimmune, neurological and psychiatric diseases","volume":"216","author":"Levite","year":"2016","journal-title":"Acta Physiol."},{"issue":"11","key":"10.1016\/j.nbd.2025.107194_bb0470","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1002\/jnr.22405","article-title":"Novel D3 dopamine receptor-preferring agonist D-264: evidence of neuroprotective property in Parkinson\u2019s disease animal models induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and lactacystin","volume":"88","author":"Li","year":"2010","journal-title":"J. Neurosci. Res."},{"issue":"05","key":"10.1016\/j.nbd.2025.107194_bb0475","article-title":"Epidemiology of traumatic brain injury over the world: a systematic review","volume":"04","author":"Li","year":"2016","journal-title":"Gener. Med."},{"key":"10.1016\/j.nbd.2025.107194_bb0480","doi-asserted-by":"crossref","first-page":"112458","DOI":"10.1016\/j.biopha.2021.112458","article-title":"Dopamine, a co-regulatory component, bridges the central nervous system and the immune system","volume":"145","author":"Li","year":"2022","journal-title":"Biomed. Pharmacother."},{"issue":"23","key":"10.1016\/j.nbd.2025.107194_bb0485","doi-asserted-by":"crossref","first-page":"16876","DOI":"10.3390\/ijms242316876","article-title":"Dopaminergic projections from the hypothalamic A11 nucleus to the spinal trigeminal nucleus are involved in bidirectional migraine modulation","volume":"24","author":"Li","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"11","key":"10.1016\/j.nbd.2025.107194_bb0490","doi-asserted-by":"crossref","first-page":"3804","DOI":"10.1093\/brain\/awae145","article-title":"Meso-cortical pathway damage in cognition, apathy and gait in cerebral small vessel disease","volume":"147","author":"Li","year":"2024","journal-title":"Brain"},{"issue":"7","key":"10.1016\/j.nbd.2025.107194_bb0495","doi-asserted-by":"crossref","first-page":"4305","DOI":"10.1073\/pnas.0730708100","article-title":"Distinct roles of dopamine D2L and D2S receptor isoforms in the regulation of protein phosphorylation at presynaptic and postsynaptic sites","volume":"100","author":"Lindgren","year":"2003","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"3","key":"10.1016\/j.nbd.2025.107194_bb0500","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1038\/s41380-021-01394-6","article-title":"Cerebral dopamine neurotrophic factor protects and repairs dopamine neurons by novel mechanism","volume":"27","author":"Lindholm","year":"2022","journal-title":"Mol. Psychiatry"},{"issue":"1","key":"10.1016\/j.nbd.2025.107194_bb0505","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0022-510X(94)00239-K","article-title":"Bromocriptine protects against delayed neuronal death of hippocampal neurons following cerebral ischemia in the gerbil","volume":"129","author":"Liu","year":"1995","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.nbd.2025.107194_bb0510","doi-asserted-by":"crossref","first-page":"e16039","DOI":"10.7717\/peerj.16039","article-title":"Pramipexole has a neuroprotective effect in spinal cord injury and upregulates D2 receptor expression in the injured spinal cord tissue in rats","volume":"11","author":"Liu","year":"2023","journal-title":"PeerJ"},{"issue":"4","key":"10.1016\/j.nbd.2025.107194_bb0515","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/j.1600-0404.2010.01395.x","article-title":"Effect of methylphenidate and\/or levodopa coupled with physiotherapy on functional and motor recovery after stroke - a randomized, double-blind, placebo-controlled trial","volume":"123","author":"Lokk","year":"2011","journal-title":"Acta Neurol. Scand."},{"issue":"1","key":"10.1016\/j.nbd.2025.107194_bb0520","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/s12964-024-01515-y","article-title":"Dopamine enhances recovery after traumatic brain injury through ubiquitylation and autophagic degradation of RIPK1","volume":"22","author":"Luo","year":"2024","journal-title":"Cell Commun. Signaling"},{"key":"10.1016\/j.nbd.2025.107194_bb0525","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/S1353-8020(09)70826-0","article-title":"Heterodimerization of dopamine receptors: new insights into functional and therapeutic significance","volume":"15","author":"Maggio","year":"2009","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.nbd.2025.107194_bb0530","first-page":"11","article-title":"Dopamine receptor subtypes, physiology and pharmacology: new ligands and concepts in schizophrenia","author":"Martel","year":"2020","journal-title":"Front. Pharmacol."},{"issue":"8","key":"10.1016\/j.nbd.2025.107194_bb0535","doi-asserted-by":"crossref","first-page":"e41","DOI":"10.1161\/CIR.0000000000001303","article-title":"2025 heart disease and stroke statistics: a report of US and global data from the American Heart Association","volume":"151","author":"Martin","year":"2025","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.nbd.2025.107194_bb0540","doi-asserted-by":"crossref","DOI":"10.1016\/j.apmr.2016.08.283","article-title":"Treating vegetative state or minimally conscious state with bromocriptine in traumatic brain injury: review of clinical cases","volume":"97","author":"Martin-Mourelle","year":"2016","journal-title":"Arch. Phys. Med. Rehabil."},{"key":"10.1016\/j.nbd.2025.107194_bb0545","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2024.1447688","article-title":"Dysregulation of the dopaminergic system secondary to traumatic brain injury: implications for mood and anxiety disorders","volume":"18","author":"Mata-Bermudez","year":"2024","journal-title":"Front. Neurosci."},{"issue":"3","key":"10.1016\/j.nbd.2025.107194_bb0550","first-page":"85","article-title":"Nucleus accumbens changes in amyotrophic lateral sclerosis","volume":"12","author":"Mavridis","year":"2023","journal-title":"Am. J. Neurodegener. Dis."},{"issue":"3","key":"10.1016\/j.nbd.2025.107194_bb0555","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1176\/jnp.23.3.jnp277","article-title":"Dopaminergic challenge with bromocriptine one month after mild traumatic brain injury: altered working memory and BOLD response","volume":"23","author":"McAllister","year":"2011","journal-title":"J. Neuropsychiatr. Clin. Neurosci."},{"issue":"4","key":"10.1016\/j.nbd.2025.107194_bb0560","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1046\/j.1471-4159.1994.63041426.x","article-title":"Alterations in regional brain catecholamine concentrations after experimental brain injury in the rat","volume":"63","author":"McIntosh","year":"1994","journal-title":"J. Neurochem."},{"issue":"2","key":"10.1016\/j.nbd.2025.107194_bb0565","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1523\/JNEUROSCI.2110-17.2017","article-title":"A critical role for dopamine D5 receptors in pain chronicity in male mice","volume":"38","author":"Megat","year":"2018","journal-title":"J. Neurosci."},{"issue":"24","key":"10.1016\/j.nbd.2025.107194_bb0570","doi-asserted-by":"crossref","first-page":"8259","DOI":"10.1523\/JNEUROSCI.4368-13.2014","article-title":"Ischemic stroke injury is mediated by aberrant Cdk5","volume":"34","author":"Meyer","year":"2014","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2025.107194_bb0575","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.neuint.2018.11.020","article-title":"Dopamine D1 receptor activation improves adult hippocampal neurogenesis and exerts anxiolytic and antidepressant-like effect via activation of Wnt\/beta-catenin pathways in rat model of Parkinson\u2019s disease","volume":"122","author":"Mishra","year":"2019","journal-title":"Neurochem. Int."},{"issue":"1","key":"10.1016\/j.nbd.2025.107194_bb0580","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1152\/physrev.1998.78.1.189","article-title":"Dopamine receptors: from structure to function","volume":"78","author":"Missale","year":"1998","journal-title":"Physiol. Rev."},{"issue":"5","key":"10.1016\/j.nbd.2025.107194_bb0585","doi-asserted-by":"crossref","first-page":"347","DOI":"10.3109\/10799893.2010.506192","article-title":"The neurobiology of dopamine receptors: evolution from the dual concept to heterodimer complexes","volume":"30","author":"Missale","year":"2010","journal-title":"J. Recept. Signal Transduction"},{"issue":"4","key":"10.1016\/j.nbd.2025.107194_bb0590","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1177\/0269881117693746","article-title":"Dopamine D <sub>4<\/sub> receptor stimulation contributes to novel object recognition: relevance to cognitive impairment in schizophrenia","volume":"31","author":"Miyauchi","year":"2017","journal-title":"J. Psychopharmacol."},{"issue":"1","key":"10.1016\/j.nbd.2025.107194_bb0595","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1749-6632.2002.tb04809.x","article-title":"Impact of subcortical ischemic lesions on behavior and cognition","volume":"977","author":"Mori","year":"2002","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"6","key":"10.1016\/j.nbd.2025.107194_bb0600","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.stem.2023.04.017","article-title":"Phase 1\/2a clinical trial in ALS with ropinirole, a drug candidate identified by iPSC drug discovery","volume":"30","author":"Morimoto","year":"2023","journal-title":"Cell Stem Cell"},{"issue":"6579","key":"10.1016\/j.nbd.2025.107194_bb0605","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/381245a0","article-title":"Localization of dopamine D4 receptors in GABAergic neurons of the primate brain","volume":"381","author":"Mrzljak","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2025.107194_bb0610","doi-asserted-by":"crossref","first-page":"103672","DOI":"10.1016\/j.nicl.2024.103672","article-title":"Progressive brain structural abnormality in cerebral small vessel disease assessed with MR imaging by using causal network analysis","volume":"44","author":"Mu","year":"2024","journal-title":"NeuroImage: Clin."},{"issue":"2","key":"10.1016\/j.nbd.2025.107194_bb0615","doi-asserted-by":"crossref","first-page":"e0149509","DOI":"10.1371\/journal.pone.0149509","article-title":"Bromocriptine Mesylate attenuates amyotrophic lateral sclerosis: a phase 2a, randomized, double-blind, placebo-controlled research in Japanese patients","volume":"11","author":"Nagata","year":"2016","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.nbd.2025.107194_bb0620","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1042\/bj20030017","article-title":"Activation of phosphoinositide 3-kinase by D2 receptor prevents apoptosis in dopaminergic cell lines","volume":"373","author":"Nair","year":"2003","journal-title":"Biochem. J."},{"issue":"5","key":"10.1016\/j.nbd.2025.107194_bb0625","doi-asserted-by":"crossref","first-page":"5042","DOI":"10.3390\/ijms24055042","article-title":"Role of dopamine in the heart in health and disease","volume":"24","author":"Neumann","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"1\u20133","key":"10.1016\/j.nbd.2025.107194_bb0630","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0014-2999(00)00562-8","article-title":"The dopamine D4 receptor: one decade of research","volume":"405","author":"Oak","year":"2000","journal-title":"Eur. J. Pharmacol."},{"issue":"7","key":"10.1016\/j.nbd.2025.107194_bb0635","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1038\/sj.jcbfm.9600078","article-title":"A dopamine D4 receptor antagonist attenuates ischemia-induced neuronal cell damage via upregulation of neuronal apoptosis inhibitory protein","volume":"25","author":"Okada","year":"2005","journal-title":"J. Cereb. Blood Flow Metab."},{"issue":"2","key":"10.1016\/j.nbd.2025.107194_bb0640","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.stem.2022.01.007","article-title":"iPSC-based disease modeling and drug discovery in cardinal neurodegenerative disorders","volume":"29","author":"Okano","year":"2022","journal-title":"Cell Stem Cell"},{"issue":"2","key":"10.1016\/j.nbd.2025.107194_bb0645","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.tips.2019.12.002","article-title":"Ropinirole, a new ALS drug candidate developed using iPSCs","volume":"41","author":"Okano","year":"2020","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.nbd.2025.107194_bb0650","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.brainres.2015.12.026","article-title":"Catecholaminergic based therapies for functional recovery after TBI","volume":"1640","author":"Osier","year":"2016","journal-title":"Brain Res."},{"issue":"7","key":"10.1016\/j.nbd.2025.107194_bb0655","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24076321","article-title":"Glia-neurotrophic factor relationships: possible role in pathobiology of Neuroinflammation-related brain disorders","volume":"24","author":"Palasz","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.nbd.2025.107194_bb0660","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainres.2008.03.010","article-title":"Lack of D2 receptor mediated regulation of dopamine synthesis in A11 diencephalospinal neurons in male and female mice","volume":"1214","author":"Pappas","year":"2008","journal-title":"Brain Res."},{"issue":"9","key":"10.1016\/j.nbd.2025.107194_bb0665","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1503\/cmaj.080282","article-title":"Traumatic brain injury: can the consequences be stopped?","volume":"178","author":"Park","year":"2008","journal-title":"Can. Med. Assoc. J."},{"issue":"3","key":"10.1016\/j.nbd.2025.107194_bb0670","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.smrv.2006.01.004","article-title":"Dopamine and the spinal cord in restless legs syndrome: does spinal cord physiology reveal a basis for augmentation?","volume":"10","author":"Paulus","year":"2006","journal-title":"Sleep Med. Rev."},{"issue":"2","key":"10.1016\/j.nbd.2025.107194_bb0675","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1017\/S1461145712000685","article-title":"A physiological role for the dopamine D5 receptor as a regulator of BDNF and Akt signalling in rodent prefrontal cortex","volume":"16","author":"Perreault","year":"2013","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"1","key":"10.1016\/j.nbd.2025.107194_bb0680","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/npp.2013.148","article-title":"Heteromeric dopamine receptor signaling complexes: emerging neurobiology and disease relevance","volume":"39","author":"Perreault","year":"2014","journal-title":"Neuropsychopharmacology"},{"issue":"9","key":"10.1016\/j.nbd.2025.107194_bb0685","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1016\/j.euroneuro.2015.07.012","article-title":"Pharmacological targeting of dopamine D3 receptors: possible clinical applications of selective drugs","volume":"25","author":"Pich","year":"2015","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"2","key":"10.1016\/j.nbd.2025.107194_bb0690","doi-asserted-by":"crossref","first-page":"139","DOI":"10.3390\/biomedicines9020139","article-title":"The role of the renal dopaminergic system and oxidative stress in the pathogenesis of hypertension","volume":"9","author":"Qaddumi","year":"2021","journal-title":"Biomedicines"},{"issue":"1","key":"10.1016\/j.nbd.2025.107194_bb0695","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/s41392-022-01064-1","article-title":"Signaling pathways involved in ischemic stroke: molecular mechanisms and therapeutic interventions","volume":"7","author":"Qin","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"issue":"7","key":"10.1016\/j.nbd.2025.107194_bb0700","doi-asserted-by":"crossref","first-page":"852","DOI":"10.2174\/1871527322666230609141519","article-title":"Oxidative stress and dopaminergic metabolism: a major PD pathogenic mechanism and basis of potential antioxidant therapies","volume":"23","author":"Rasool","year":"2024","journal-title":"CNS Neurol. Disord. Drug Targets"},{"issue":"5","key":"10.1016\/j.nbd.2025.107194_bb0705","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.devcel.2013.04.012","article-title":"Dopamine from the brain promotes spinal motor neuron generation during development and adult regeneration","volume":"25","author":"Reimer","year":"2013","journal-title":"Dev. Cell"},{"issue":"14","key":"10.1016\/j.nbd.2025.107194_bb0710","doi-asserted-by":"crossref","first-page":"3336","DOI":"10.1111\/bph.16388","article-title":"Differential G protein activation by the long and short isoforms of the dopamine D <sub>2<\/sub> receptor","volume":"182","author":"Reiner-Link","year":"2024","journal-title":"Br. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.nbd.2025.107194_bb0715","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1006\/exnr.1997.6525","article-title":"Asymmetrical protection of Neostriatal neurons against transient forebrain ischemia by unilateral dopamine depletion","volume":"146","author":"Ren","year":"1997","journal-title":"Exp. Neurol."},{"issue":"7","key":"10.1016\/j.nbd.2025.107194_bb0720","doi-asserted-by":"crossref","first-page":"4693","DOI":"10.1007\/s00415-024-12435-9","article-title":"Update on recent advances in amyotrophic lateral sclerosis","volume":"271","author":"Riva","year":"2024","journal-title":"J. Neurol."},{"issue":"2","key":"10.1016\/j.nbd.2025.107194_bb0725","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.expneurol.2009.04.030","article-title":"Mitochondrial mechanisms of cell death and neuroprotection in pediatric ischemic and traumatic brain injury","volume":"218","author":"Robertson","year":"2009","journal-title":"Exp. Neurol."},{"issue":"7","key":"10.1016\/j.nbd.2025.107194_bb0730","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/S1474-4422(02)00190-4","article-title":"Subcortical ischaemic vascular dementia","volume":"1","author":"Roman","year":"2002","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.nbd.2025.107194_bb0735","series-title":"The Dopamine Receptors","first-page":"137","article-title":"Dopamine receptor signaling: Intracellular pathways to behavior","author":"Romanelli","year":"2010"},{"issue":"2","key":"10.1016\/j.nbd.2025.107194_bb0740","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1161\/STROKEAHA.111.638767","article-title":"Levodopa treatment improves functional recovery after experimental stroke","volume":"43","author":"Ruscher","year":"2012","journal-title":"Stroke"},{"issue":"6","key":"10.1016\/j.nbd.2025.107194_bb0745","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1017\/neu.2015.17","article-title":"The effectiveness of dopamine agonists for treatment of neuropsychiatric symptoms post brain injury and stroke","volume":"27","author":"Sami","year":"2015","journal-title":"Acta Neuropsychiatr."},{"issue":"12","key":"10.1016\/j.nbd.2025.107194_bb0750","doi-asserted-by":"crossref","first-page":"2978","DOI":"10.1161\/01.STR.0000038093.42512.0F","article-title":"Endogenous dopamine amplifies ischemic long-term potentiation via D1 receptors","volume":"33","author":"Saulle","year":"2002","journal-title":"Stroke"},{"issue":"9284","key":"10.1016\/j.nbd.2025.107194_bb0755","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/S0140-6736(01)05966-9","article-title":"Effect of levodopa in combination with physiotherapy on functional motor recovery after stroke: a prospective, randomised, double-blind study","volume":"358","author":"Scheidtmann","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.nbd.2025.107194_bb0760","series-title":"The Dopamine Receptors","first-page":"1","article-title":"Historical overview: Introduction to the dopamine receptors","author":"Seeman","year":"2010"},{"issue":"6","key":"10.1016\/j.nbd.2025.107194_bb0765","doi-asserted-by":"crossref","first-page":"927","DOI":"10.3390\/brainsci13060927","article-title":"Neural injury of the dopaminergic pathways in patients with middle cerebral artery territory infarct: a diffusion tensor imaging study","volume":"13","author":"Seo","year":"2023","journal-title":"Brain Sci."},{"issue":"1","key":"10.1016\/j.nbd.2025.107194_bb0770","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1038\/s41531-024-00836-6","article-title":"Molecular and cellular determinants of L-Dopa-induced dyskinesia in Parkinson\u2019s disease","volume":"10","author":"Servillo","year":"2024","journal-title":"NPJ Parkinsons Dis."},{"key":"10.1016\/j.nbd.2025.107194_bb0775","first-page":"8","article-title":"Dopamine: a parallel pathway for the modulation of spinal locomotor networks","author":"Sharples","year":"2014","journal-title":"Front. Neural Circuits"},{"issue":"1","key":"10.1016\/j.nbd.2025.107194_bb0780","doi-asserted-by":"crossref","first-page":"16429","DOI":"10.1038\/s41598-020-73230-w","article-title":"A dynamic role for dopamine receptors in the control of mammalian spinal networks","volume":"10","author":"Sharples","year":"2020","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.nbd.2025.107194_bb0785","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1177\/154596830101500305","article-title":"Selegiline treatment facilitates recovery after stroke","volume":"15","author":"Sivenius","year":"2001","journal-title":"Neurorehabil. Neural Repair"},{"key":"10.1016\/j.nbd.2025.107194_bb0790","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.neubiorev.2016.05.021","article-title":"Reappraising striatal D1- and D2-neurons in reward and aversion","volume":"68","author":"Soares-Cunha","year":"2016","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"6","key":"10.1016\/j.nbd.2025.107194_bb0795","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1161\/STROKEAHA.125.050674","article-title":"Dopaminergic pathways in neuroplasticity after stroke and Vagus nerve stimulation","volume":"56","author":"Song","year":"2025","journal-title":"Stroke"},{"issue":"4","key":"10.1016\/j.nbd.2025.107194_bb0800","doi-asserted-by":"crossref","first-page":"735","DOI":"10.3390\/cells10040735","article-title":"Dopamine: the neuromodulator of long-term synaptic plasticity, reward and movement control","volume":"10","author":"Speranza","year":"2021","journal-title":"Cells"},{"issue":"2","key":"10.1016\/j.nbd.2025.107194_bb0805","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/NRL.0000000000000001","article-title":"Amantadine for patients with severe traumatic brain injury","volume":"19","author":"Spritzer","year":"2015","journal-title":"Neurologist"},{"issue":"5","key":"10.1016\/j.nbd.2025.107194_bb0810","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1080\/026990597123494","article-title":"Cognitive effects of antipsychotic agents in persons with traumatic brain injury","volume":"11","author":"Stanislav","year":"1997","journal-title":"Brain Inj."},{"issue":"4","key":"10.1016\/j.nbd.2025.107194_bb0815","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1097\/JTN.0000000000000138","article-title":"Amantadine to treat cognitive dysfunction in moderate to severe traumatic brain injury","volume":"22","author":"Stelmaschuk","year":"2015","journal-title":"J. Trauma Nurs."},{"issue":"9","key":"10.1016\/j.nbd.2025.107194_bb0820","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1016\/j.jstrokecerebrovasdis.2018.04.028","article-title":"Post-stroke movement disorders: the clinical, neuroanatomic, and demographic portrait of 284 published cases","volume":"27","author":"Suri","year":"2018","journal-title":"J. Stroke Cerebrovasc. Dis."},{"issue":"8878","key":"10.1016\/j.nbd.2025.107194_bb0825","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/0140-6736(93)92878-W","article-title":"Evidence for a dopaminergic deficit in sporadic amyotrophic lateral sclerosis on positron emission scanning","volume":"342","author":"Takahashi","year":"1993","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.nbd.2025.107194_bb0830","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/0006-8993(90)90744-V","article-title":"Atrophy of the ipsilateral substantia nigra following middle cerebral artery occlusion in the rat","volume":"510","author":"Tamura","year":"1990","journal-title":"Brain Res."},{"issue":"2","key":"10.1016\/j.nbd.2025.107194_bb0835","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.expneurol.2008.02.004","article-title":"A dopamine receptor antagonist L-745,870 suppresses microglia activation in spinal cord and mitigates the progression in ALS model mice","volume":"211","author":"Tanaka","year":"2008","journal-title":"Exp. Neurol."},{"issue":"1","key":"10.1016\/j.nbd.2025.107194_bb0840","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.expneurol.2011.08.001","article-title":"Bromocriptine methylate suppresses glial inflammation and moderates disease progression in a mouse model of amyotrophic lateral sclerosis","volume":"232","author":"Tanaka","year":"2011","journal-title":"Exp. Neurol."},{"issue":"8","key":"10.1016\/j.nbd.2025.107194_bb0845","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1111\/j.1460-9568.1997.tb01529.x","article-title":"Involvement of activation of Dopamineraic neuronal system in learning and memory deficits associated with experimental mild traumatic brain injury","volume":"9","author":"Tang","year":"1997","journal-title":"Eur. J. Neurosci."},{"issue":"2","key":"10.1016\/j.nbd.2025.107194_bb0850","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/s41419-017-0221-2","article-title":"Dopamine D2 receptor-mediated neuroprotection in a G2019S Lrrk2 genetic model of Parkinson\u2019s disease","volume":"9","author":"Tozzi","year":"2018","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.nbd.2025.107194_bb0855","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.neuron.2012.09.023","article-title":"Dopaminergic modulation of synaptic transmission in cortex and striatum","volume":"76","author":"Tritsch","year":"2012","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2025.107194_bb0860","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.neuroimage.2019.01.062","article-title":"Functional neuroanatomical review of the ventral tegmental area","volume":"191","author":"Trutti","year":"2019","journal-title":"NeuroImage"},{"issue":"10","key":"10.1016\/j.nbd.2025.107194_bb0865","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1002\/syn.20432","article-title":"D <sub>2<\/sub> dopamine receptors recruit a GABA component for their attenuation of excitatory synaptic transmission in the adult rat prefrontal cortex","volume":"61","author":"Tseng","year":"2007","journal-title":"Synapse"},{"issue":"1","key":"10.1016\/j.nbd.2025.107194_bb0870","doi-asserted-by":"crossref","first-page":"17","DOI":"10.4103\/aian.AIAN_194_18","article-title":"Vascular parkinsonism: a review on management updates","volume":"22","author":"Udagedara","year":"2019","journal-title":"Ann. Indian Acad. Neurol."},{"issue":"1","key":"10.1016\/j.nbd.2025.107194_bb0875","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.pharmthera.2010.05.003","article-title":"Pharmacology of signaling induced by dopamine D1-like receptor activation","volume":"128","author":"Undieh","year":"2010","journal-title":"Pharmacol. Ther."},{"issue":"6809","key":"10.1016\/j.nbd.2025.107194_bb0880","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/35041572","article-title":"Distinct functions of the two isoforms of dopamine D2 receptors","volume":"408","author":"Usiello","year":"2000","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.nbd.2025.107194_bb0885","doi-asserted-by":"crossref","first-page":"e455","DOI":"10.1038\/cddis.2012.194","article-title":"Dopamine protects neurons against glutamate-induced excitotoxicity","volume":"4","author":"Vaarmann","year":"2013","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.nbd.2025.107194_bb0890","series-title":"Amyotrophic Lateral Sclerosis; Clinical Features, Differential Diagnosis and Pathology","first-page":"1","author":"Van Es","year":"2024"},{"issue":"4","key":"10.1016\/j.nbd.2025.107194_bb0895","doi-asserted-by":"crossref","first-page":"538","DOI":"10.3171\/jns.2007.106.4.538","article-title":"Sex and genetic associations with cerebrospinal fluid dopamine and metabolite production after severe traumatic brain injury","volume":"106","author":"Wagner","year":"2007","journal-title":"J. Neurosurg."},{"issue":"4","key":"10.1016\/j.nbd.2025.107194_bb0900","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1111\/j.1471-4159.2008.05840.x","article-title":"Chronic methylphenidate treatment enhances striatal dopamine neurotransmission after experimental traumatic brain injury","volume":"108","author":"Wagner","year":"2009","journal-title":"J. Neurochem."},{"issue":"3","key":"10.1016\/j.nbd.2025.107194_bb0905","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S0306-4522(02)00113-6","article-title":"Activation of presynaptic D1 dopamine receptors by dopamine increases the frequency of spontaneous excitatory postsynaptic currents through protein kinase a and protein kinase C in pyramidal cells of rat prelimbic cortex","volume":"112","author":"Wang","year":"2002","journal-title":"Neuroscience"},{"issue":"1","key":"10.1016\/j.nbd.2025.107194_bb0910","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1080\/17482960701791234","article-title":"R(+) pramipexole as a mitochondrially focused neuroprotectant: initial early phase studies in ALS","volume":"9","author":"Wang","year":"2008","journal-title":"Amyotroph. Lateral Scler."},{"issue":"5","key":"10.1016\/j.nbd.2025.107194_bb0915","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1093\/ijnp\/pyy005","article-title":"The dopamine receptor D3 regulates lipopolysaccharide-induced depressive-like behavior in mice","volume":"21","author":"Wang","year":"2018","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"3","key":"10.1016\/j.nbd.2025.107194_bb0920","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/s41401-021-00650-3","article-title":"Exogenous glutathione exerts a therapeutic effect in ischemic stroke rats by interacting with intrastriatal dopamine","volume":"43","author":"Wang","year":"2022","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.nbd.2025.107194_bb0925","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.brainresbull.2021.10.015","article-title":"Pramipexole regulates depression-like behavior via dopamine D3 receptor in a mouse model of Parkinson\u2019s disease","volume":"177","author":"Wei","year":"2021","journal-title":"Brain Res. Bull."},{"issue":"1","key":"10.1016\/j.nbd.2025.107194_bb0930","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.neuroscience.2005.09.028","article-title":"Under the curve: critical issues for elucidating D1 receptor function in working memory","volume":"139","author":"Williams","year":"2006","journal-title":"Neuroscience"},{"issue":"6","key":"10.1016\/j.nbd.2025.107194_bb0935","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1097\/WNR.0b013e32832a0a98","article-title":"Dopamine D1-like receptor activation induces brain-derived neurotrophic factor protein expression","volume":"20","author":"Williams","year":"2009","journal-title":"Neuroreport"},{"issue":"1","key":"10.1016\/j.nbd.2025.107194_bb0940","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/s41392-023-01427-2","article-title":"G protein-coupled receptors in neurodegenerative diseases and psychiatric disorders","volume":"8","author":"Wong","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.nbd.2025.107194_bb0945","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2019.105908","article-title":"The modulatory role of dopamine receptors in brain neuroinflammation","volume":"76","author":"Xia","year":"2019","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.nbd.2025.107194_bb0950","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.brainres.2008.02.009","article-title":"Dopamine receptor gene expression in human amygdaloid nuclei: elevated D4 receptor mRNA in major depression","volume":"1207","author":"Xiang","year":"2008","journal-title":"Brain Res."},{"issue":"1\u20132","key":"10.1016\/j.nbd.2025.107194_bb0955","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.cell.2014.11.047","article-title":"Dopamine controls systemic inflammation through inhibition of NLRP3 Inflammasome","volume":"160","author":"Yan","year":"2015","journal-title":"Cell"},{"issue":"19","key":"10.1016\/j.nbd.2025.107194_bb0960","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1161\/01.CIR.101.19.2302","article-title":"Dopamine as a novel antioxidative agent for rat vascular smooth muscle cells through dopamine D(1)-like receptors","volume":"101","author":"Yasunari","year":"2000","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.nbd.2025.107194_bb0965","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1046\/j.1471-4159.1994.62031034.x","article-title":"Antioxidant properties of bromocriptine, a dopamine agonist","volume":"62","author":"Yoshikawa","year":"1994","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2025.107194_bb0970","doi-asserted-by":"crossref","first-page":"172826","DOI":"10.1016\/j.ejphar.2019.172826","article-title":"Dopamine attenuates lipopolysaccharide-induced expression of proinflammatory cytokines by inhibiting the nuclear translocation of NF-\u03baB p65 through the formation of dopamine quinone in microglia","volume":"866","author":"Yoshioka","year":"2020","journal-title":"Eur. J. Pharmacol."},{"issue":"8","key":"10.1016\/j.nbd.2025.107194_bb0975","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1161\/STROKEAHA.107.506824","article-title":"Dopamine D1-like receptors depress excitatory synaptic transmissions in striatal neurons after transient forebrain ischemia","volume":"39","author":"Zhang","year":"2008","journal-title":"Stroke"},{"issue":"4","key":"10.1016\/j.nbd.2025.107194_bb0980","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.neuroscience.2007.07.052","article-title":"Expression and distribution of all dopamine receptor subtypes (D1\u2013D5) in the mouse lumbar spinal cord: a real-time polymerase chain reaction and non-autoradiographic in situ hybridization study","volume":"149","author":"Zhu","year":"2007","journal-title":"Neuroscience"},{"issue":"9","key":"10.1016\/j.nbd.2025.107194_bb0985","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/S2215-0366(17)30270-5","article-title":"Antipsychotic drugs for the acute treatment of patients with a first episode of schizophrenia: a systematic review with pairwise and network meta-analyses","volume":"4","author":"Zhu","year":"2017","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.nbd.2025.107194_bb0990","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.bbi.2020.08.025","article-title":"Drd2 biased agonist prevents neurodegeneration against NLRP3 inflammasome in Parkinson\u2019s disease model via a \u03b2-arrestin2-biased mechanism","volume":"90","author":"Zhu","year":"2020","journal-title":"Brain Behav. Immun."}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996125004115?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996125004115?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T15:04:00Z","timestamp":1773932640000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996125004115"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":198,"alternative-id":["S0969996125004115"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2025.107194","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of dopaminergic signalling from physiology to neuroprotection in acute and chronic disorders","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2025.107194","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"107194"}}